Predicting opioid therapy safety in pancreatic cancer patients

Predicting opioid therapy safety in pancreatic cancer patients

Background — Obligatory use of strong opioids for treating chronic pain syndrome in patients with pancreatic cancer provides the implementation of opioid-associated adverse reactions. Genetic and non-genetic risk factors are predictive of the opioid therapy safety. Contemporary methods of informatio...

Full description

Bibliographic Details
Main Authors: Olga P. Bobrova, Sergei K. Zyryanov, Natalya A. Shnayder, Marina M. Petrova
Format: Article
Language:English
Published: Limited liability company «Science and Innovations» (Saratov) 2020-12-01
Series:Russian Open Medical Journal
Subjects:
oncology
risk factors
personalized medicine
chronic pain syndrome
safety
morphine sulfate
fentanyl transdermal therapeutic system
adverse drug reactions
pharmacogenetics
Online Access:http://www.romj.org/node/337

Similar Items

Similar Items